MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
629.43%
Quick Ratio
497.40%
Cash Ratio
81.27%
Debt to Asset Ratio
55.23%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, current
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
30,562 35,006 36,437 39,559
Short-term investments
126,144 133,940 142,201 144,531
Accounts receivable, net
25,322 28,329 32,962 34,891
Inventories
49,650 47,609 49,289 52,249
Prepaid expenses and other current assets
5,031 5,999 4,478 4,348
Total current assets
236,709 250,883 265,367 275,578
Restricted cash
3,829 3,829 3,329 3,329
Total property and equipment
NaN 29,569 NaN NaN
Less accumulated depreciation and amortization
NaN 24,899 NaN NaN
Property and equipment, net
4,073 4,670 5,254 6,166
Operating lease right-of-use assets
4,410 4,797 2,767 3,168
Finance lease right-of-use assets
80 NaN NaN NaN
Other assets
353 317 538 560
Total assets
249,454 264,496 277,255 288,801
Accounts payable
1,440 554 1,724 1,445
Accrued compensation and related benefits
8,754 10,735 10,855 9,789
Accrued expenses and other current liabilities
11,599 9,433 6,692 8,518
Accrued warranty liability
1,352 1,374 1,363 1,239
Deferred revenue, current
12,641 13,795 14,900 14,009
Operating lease liabilities, current
1,795 1,739 1,912 1,909
Finance lease liabilities, current
26 NaN NaN NaN
Total current liabilities
37,607 37,630 37,446 36,909
Accrued interest
NaN 0 0 0
Deferred revenue
366 406 676 587
Operating lease liabilities
2,797 3,271 1,244 1,707
Finance lease liabilities
59 NaN NaN NaN
Term loan
96,937 96,237 95,524 94,814
Total liabilities
137,766 137,544 134,890 134,017
Preferred stock, 0.001 par value 5,000 shares authorized as of september 30, 2025 and december 31, 2024 21 and 0 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
NaN NaN 3,841 3,841
Common stock, 0.001 par value 300,000 shares authorized as of march 31, 2026 and december 31, 2025 18,529 and 18,169 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
18 18 18 18
Additional paid-in capital
1,302,097 1,298,138 1,290,234 1,284,923
Accumulated other comprehensive loss
-73 172 157 49
Accumulated deficit
-1,190,354 -1,171,376 -1,151,885 -1,134,047
Total stockholders' equity
111,688 126,952 142,365 154,784
Total liabilities and stockholders' equity
249,454 264,496 277,255 288,801
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$126,144K Inventories$49,650K Cash and cashequivalents$30,562K Accounts receivable, net$25,322K Prepaid expenses andother current assets$5,031K Total current assets$236,709K Operating leaseright-of-use assets$4,410K Property and equipment,net$4,073K Restricted cash$3,829K Other assets$353K Finance leaseright-of-use assets$80K Total assets$249,454K Total liabilities andstockholders' equity$249,454K Total liabilities$137,766K Total stockholders'equity$111,688K Accumulated deficit-$1,190,354K Accumulated othercomprehensive loss-$73K Term loan$96,937K Total currentliabilities$37,607K Operating leaseliabilities$2,797K Deferred revenue$366K Finance leaseliabilities$59K Additional paid-in capital$1,302,097K Common stock, 0.001 parvalue 300,000 shares...$18K Deferred revenue,current$12,641K Accrued expenses andother current...$11,599K Accrued compensationand related...$8,754K Operating leaseliabilities, current$1,795K Accounts payable$1,440K Accrued warrantyliability$1,352K Finance leaseliabilities, current$26K

Outset Medical, Inc. (OM)

Outset Medical, Inc. (OM)